← Evidence map

ReviewCancers2022

Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review.

Mattia Garutti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35454806